Creative Destruction Lab (CDL) is pleased to announce that the Alberta Cancer Foundation (ACF) is joining the CDL Cancer program. This partnership brings together a shared commitment to accelerate the development and commercialization of cutting-edge technologies that aim to transform the future of cancer care.
Launched in 2022 in partnership with the Canadian Cancer Society, CDL Cancer is a unique startup program designed for founders commercializing transformative technologies that aim to change the standard of cancer care and improve patient outcomes. Alberta Cancer Foundation joins this initiative in 2025, further strengthening CDL’s mission to enhance the commercialization of science for the betterment of humankind.
Health Technology Insights: SCIEX Appoints Chris Hagen as President
Since its launch, CDL Cancer has graduated 18 startups that have collectively generated more than $375 million in equity value. Approximately 80% of these companies are projected to be in the clinic by 2027, with innovations that will improve the lives of an estimated 24 million+ patients globally.
CDL Cancer is delivered in partnership with founding partner, Canadian Cancer Society, and hosted at CDL-Toronto (Rotman School of Management, University of Toronto), CDL-Vancouver (Sauder School of Business, University of British Columbia), and in the 2025/26 program year, CDL will expand the program’s national reach with CDL-Rockies (Haskayne School of Business, University of Calgary). Beginning in October 2025 and concluding in June 2026, the nine-month program features four objective-setting sessions that connect founders with world-class mentors to refine their strategy, attract capital, and accelerate progress.
Health Technology Insights: qiibee Partners with US Health Insurer Moda Health to Revolutionize Healthcare Rewards
“Cancer touches the lives of nearly every person, whether directly or through a loved one. CDL supports founders who are working on breakthrough technologies across the cancer care continuum, and creating a pathway to impact millions of patients and families around the world,” said Sonia Sennik, Chief Executive Officer of Creative Destruction Lab. “Welcoming the Alberta Cancer Foundation as a CDL Cancer partner strengthens our ability to support Canada’s healthcare and research communities.”
“Cancer is an enormously complex challenge that takes all of us, working together, to address. Welcoming the Alberta Cancer Foundation as a partner on the CDL Cancer program strengthens our shared goal of improving the cancer experience for everyone, said Andrea Seale, CEO of the Canadian Cancer society. “We have big ambitions and are confident that together we can achieve them.”
“We’re proud to partner with CDL Cancer to help accelerate bold ideas that have the power to transform cancer care,” said Wendy Beauchesne, CEO of the Alberta Cancer Foundation. “Together, we’re creating more hope, more innovation, and more moments for those facing cancer.”
Health Technology Insights: CytoSorbents Appoints Thomas Shannon VP of Marketing, NA
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobalNewswire
